Revolution Medicines, Inc. is 1.1x more valuable than BIOGEN INC. by market capitalization ($30.65 B vs $28.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BIIB | RVMD |
|---|---|---|
| Market cap | $28.68 B | $30.65 B |
| US-listed rank | #476 | #454 |
| Revenue (latest FY) | $9.89B | $0.00 |
| Net income (latest FY) | $1.29B | -$1.13B |
| Net margin | 13.1% | - |
| P/E (trailing FY) | 22.2 | - |
| SEC filings | 2,690 | 782 |
Revolution Medicines, Inc. is 1.1x more valuable than BIOGEN INC. by market capitalization ($30.65 B vs $28.68 B).
In their latest fiscal years, BIOGEN INC. reported $9.89B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: BIOGEN INC. and Revolution Medicines, Inc., or browse the full rankings.